Cost-benefit impact of free asthma medication provision for the pediatric population

• Published in: Respiratory medicine Vol. 164; p. 105915
• Main Authors: Koltermann, Vanessa, Friedrich, Frederico Orlando, Fensterseifer, Ana Carolina, Ongaratto, Renata, Pinto, Leonardo Araújo
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.04.2020; Elsevier Limited
• Subjects: Access to information; Age groups; Asthma; Asthma admissions; Children; Chronic illnesses; Confidence intervals; Corticosteroids; Cost benefit analysis; Cost control; Cost estimates; Costs; Epidemiology; Health care; Hospitals; Information technology; Inhaled corticosteroids; Morbidity; Mortality; Patient admissions; Pediatrics; Population; Population studies; Public health; Public health care systems; Respiratory diseases; Brazil; United States > US; Costs; Inhaled corticosteroids; Public health care systems; Asthma admissions

Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the po...